Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection

Journal of Infectious Diseases

Volumn 202, Issue 7, 2010, Pages 1041-1049

  Kwieciński, Jakub ^a   Josefsson, Elisabet ^a   Mitchell, Jennifer ^b   Higgins, Judy ^a,c   Magnusson, Mattias ^a,b,c   Foster, Timothy ^b   Jin, Tao ^a   Bokarewa, Maria ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BACTERIAL DNA; BACTERIAL ENZYME; GENOMIC DNA; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN A; STAPHYLOKINASE; TISSUE PLASMINOGEN ACTIVATOR; AUR PROTEIN, STAPHYLOCOCCUS AUREUS; BACTERIAL PROTEIN; METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; CONGENIC STRAIN; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME SYNTHESIS; FIBRINOLYSIS; GENE OVEREXPRESSION; HUMAN; KIDNEY; MOLECULAR CLONING; MORTALITY; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STAPHYLOKINASE GENE; SURVIVAL; TRANSGENIC MOUSE; WEIGHT REDUCTION; ANIMAL; BACTERIAL COUNT; C57BL MOUSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; GENETICS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

ANIMALS; BACTERIAL PROTEINS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTAGENESIS, INSERTIONAL; PLASMINOGEN; RECOMBINATION, GENETIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS;

EID: 77956927838     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/656140     Document Type: Article

References (40)

1. Klevens RM, Morrison MA, Nadle J, et al. Invasivemethicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-1771.
2. Collen D. Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent. Nat Med 1998; 4:279-284.
3. Collen D, Lijnen HR. Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential? Blood 1994; 84:680-686.
4. Okada K, Ueshima S, Tanaka M, Fukao H, Matsuo O. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice. Blood Coagul Fibrinolysis 2000; 11:645-655.
5. Sako T, Sawaki S, Sakurai T, Ito S, Yoshizawa Y, Kondo I. Cloning and expression of the staphylokinase gene of Staphylococcus aureus in Escherichia coli. Mol Gen Genet 1983; 190:271-277. (Pubitemid 13025576)
6. Behnke D, Gerlach D. Cloning and expression in Escherichia coli, Bacillus subtilis, and Streptococcus sanguis of a gene for staphylokinase - a bacterial plasminogen activator. Mol Gen Genet 1987; 210:528-534.
7. Coleman DC, Sullivan DJ, Russell RJ, Arbuthnott JP, Carey BF, Pomeroy HM. Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: molecular mechanism of triple conversion. J Gen Microbiol 1989; 135:1679-1697.
8. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP. Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet 1986; 202:58-61.
9. Ziebandt AK, Weber H, Rudolph J, et al. Extracellular proteins of Staphylococcus aureus and the role of SarA and sigma B. Proteomics 2001; 1:480-493.
10. Jin T, Bokarewa M, McIntyre L, et al. Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol 2003; 52:919-923.
11. Christner RB, Boyle MD. Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci. J Infect Dis 1996; 173:104-112.
12. Boyle MD,Lottenberg R. Plasminogen activation by invasive human pathogens. Thromb Haemost 1997; 77:1-10.
13. Kuusela P, Saksela O. Binding and activation of plasminogen at the surface of Staphylococcus aureus: increase in affinity after conversion to the Lys form of the ligand. Eur J Biochem 1990; 193:759-765.
14. Molkanen T, Tyynela J, Helin J, Kalkkinen N, Kuusela P. Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase. FEBS Lett 2002; 517:72-78.
15. Kuusela P, Ullberg M, Saksela O, Kronvall G. Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci. Infect Immun 1992; 60:196-201.
16. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 2004; 172:1169-1176.
17. Rooijakkers SH, van Wamel WJ, Ruyken M, van Kessel KP, van Strijp JA. Anti-opsonic properties of staphylokinase. Microbes Infect 2005; 7:476-484.
18. Sun H, Ringdahl U, Homeister JW, et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004; 305:1283-1286.
19. Lee CY, Buranen SL, Ye ZH. Construction of single-copy integration vectors for Staphylococcus aureus. Gene 1991; 103:101-105.
20. Bremell T, Lange S, Yacoub A, Ryden C, Tarkowski A. Experimental Staphylococcus aureus arthritis in mice. Infect Immun 1991; 59:2615-2623.
21. Augustin J, Gotz F. Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. FEMS Microbiol Lett 1990; 54:203-207.
22. Ausubel FM, Brent R, Kingston RE, et al, eds. Current protocols in molecular biology. New York, NY: John Wiley & Sons, 1987.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
24. Patel AH, Kornblum J, Kreiswirth B, Novick R, Foster TJ. Regulation of the protein A-encoding gene in Staphylococcus aureus. Gene 1992; 114:25-34.
25. Foster TJ. Molecular genetic analysis of staphylococcal virulence. Methods Microbiol 1998; 27:433-454. (Pubitemid 128142271)
26. Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 2001; 184:1572-1580.
27. Jin T, Bokarewa M, Tarkowski A. Urokinase-type plasminogen activator, an endogenous antibiotic. J Infect Dis 2005; 192:429-437.
28. Kidokoro A, Iba T, Fukunaga M, Yagi Y. Alterations in coagulation and fibrinolysis during sepsis. Shock 1996; 5:223-228.
29. Querol-Ribelles JM, Tenias JM, Grau E, et al. Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest 2004; 126:1087-1092.
30. Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ. Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiol Lett 2006; 258:290-296.
31. Josefsson E, Higgins J, Foster TJ, Tarkowski A. Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PloS ONE 2008; 3:e2206.
32. Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998; 6:484-488.
33. Lähteenmäki K, Edelman S, Korhonen TK. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol 2005; 13:79-85. (Pubitemid 40174867)
34. Renckens R, Roelofs JJ, Florquin S, et al. Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice. J Immunol 2006; 177:1189-1196.
35. Roelofs JJ, Rouschop KM, Teske GJ, et al. Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection. Nephrol Dial Transplant 2009; 24:801-808.
36. Beck JM, Preston AM, Gyetko MR. Urokinase-type plasminogen activator in inflammatory cell recruitment and host defence against Pneumocystis carinii in mice. Infect Immun 1999; 67:879-884.
37. Gyetko MR, Chen GH, McDonald RA, et al. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. J Clin Invest 1996; 97:1818-1826.
38. Jin T, Bokarewa M, Tarkowski A. The role of urokinase in innate immunity against Staphylococcus aureus. Microbes Infect 2005; 7:1170-1175.
39. Shapiro RL, Duquette JG, Nunes I, et al. Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles. Am J Pathol 1997; 150:359-369. (Pubitemid 27027125)
40. Guo Y, Li J, Hagström E, Ny T. Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. Arthritis Rheum 2008; 58:764-772.